5-ARIs May Protect Against Bladder Cancer Progression
5α-reductase inhibitors are widely used to treat lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH).
5α-reductase inhibitors are widely used to treat lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH).
Results are from a meta-analysis of 33 trials involving 35,939 patients with overactive bladder.
Association especially strong among the elderly male population
Investigators comment on the first US-based prevalence study of nocturnal polyuria that collected frequency volume diary data in a non-clinic population.
Prostatic artery embolization is a minimally invasive surgical technique that involves selective cannulation of the prostatic arteries.
Bothersome or not, lower urinary tract symptoms increase mortality risk in men.
A Japanese study is the first to demonstrate the potential of saw palmetto extract to ameliorate lower urinary tract symptoms in adult women, according to investigators.
The likelihood of conversion from HoLEP to an open procedure to treat benign prostatic hyperplasia increases along with prostate size.
Results of an analysis of the effects of BMI and pelvic floor muscle exercise on quality of life for men with after undergoing surgery for prostate cancer.
Clinical and urodynamic criteria for antimuscarinic nonresponse in men are needed along with more quality research on treatment alternatives.